Skip to main content
. 2021 Oct 12;2021(10):CD011589. doi: 10.1002/14651858.CD011589.pub2

NCT03850912.

Study name SIMPRO Research Center: Integration and Implementation of PROs for Symptom Management in Oncology Practice
Methods Randomised parallel trial, USA
Participants Adults aged >= 18 years, who meet one of the following:
  • Suspected thoracic cancer [lung or bronchus] AND is inpatient following thoracic surgery.

  • Suspected gastrointestinal cancer [colorectal, pancreas, liver/biliary, esophagus,or gastric] AND is inpatient following gastrointestinal surgery.

  • Suspected gynecologic cancer [ovary, uterus, or cervix] AND is inpatient following gynecologic surgery.

  • Diagnosis of thoracic cancer [lung or bronchus] AND scheduled to start a new treatment plan for thoracic cancer.

  • Diagnosis of gastrointestinal cancer [colorectal, pancreas, liver/biliary, esophagus,or gastric] AND scheduled to start a new treatment plan for gastrointestinal cancer.

  • Diagnosis of gynecologic cancer [ovary, uterus, or cervix] AND scheduled to start a new treatment plan for gynecologic cancer

Interventions Intervention: participants will receive patient‐reported outcome measures and receive feedback
Comparison: participants will receive patient‐reported outcome measures and not receive feedback
Outcomes Main outcome: 'Emergency Department ‐ Treat and Release' (EDTR) Rate at 30‐days
Other outcomes: symptom burden, patient satisfaction, initiation of adjuvant chemotherapy, sustainability of the intervention
Starting date July 2019 (estimated completion date September 2023)
Contact information Deborah Schrag
Notes